Inflammasomes and Cardiovascular Disease: Linking Inflammation to Cardiovascular Pathophysiology
Scandinavian Journal of Immunology · 2025-04 · 101 (4)
DOI: 10.1111/sji.70020 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Scandinavian Journal of Immunology, 2025-04. Verfasst von Mohamed J Saadh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Middle East University, Amman, Jordan. Hauptthemen laut MEDLINE: Inflammasomes, Cardiovascular Diseases, Inflammation. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 163 Literaturangaben.
Abstract (Originalsprache)
Cardiovascular diseases (CVDs) remain a leading cause of global mortality, driven by risk factors such as dyslipidemia, hypertension and diabetes. Recent research has highlighted the critical role of inflammasomes, particularly the NLRP3 inflammasome, in the pathogenesis of various CVDs, including hypertension, atherosclerosis, myocardial infarction and heart failure. Inflammasomes are intracellular protein complexes that activate inflammatory responses through the production of pro‐inflammatory cytokines such as IL‐1β and IL‐18, contributing to endothelial dysfunction, plaque formation and myocardial injury. This review provides a comprehensive overview of the structure, activation mechanisms and pathways of inflammasomes, with a focus on their involvement in cardiovascular pathology. Key activation pathways include ion fluxes (K + efflux and Ca 2+ signalling), endoplasmic reticulum (ER) stress, mitochondrial dysfunction and lysosomal destabilisation. The review also explores the therapeutic potential of targeting inflammasomes to mitigate inflammation and improve outcomes in CVDs. Emerging strategies include small‐molecule inhibitors, biologics and RNA‐based therapeutics, with a particular emphasis on NLRP3 inhibition. Additionally, the integration of artificial intelligence (AI) in cardiovascular research offers promising avenues for identifying novel biomarkers, predicting disease risk and developing personalised treatment strategies. Future research directions should focus on understanding the interactions between inflammasomes and other immune components, as well as genetic regulators, to uncover new therapeutic targets. By elucidating the complex role of inflammasomes in CVDs, this review underscores the potential for innovative therapies to address inflammation‐driven cardiovascular pathology, ultimately improving patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Middle East University, Amman, Jordan.
- College of Pharmacy, Alnoor University, Nineveh, Iraq.
- Ahl Al Bayt University, Karbala, Iraq.
- Marwadi University Research Center, Department of Microbiology Faculty of Science, Marwadi University, Rajkot, Gujarat, India.
- Department of Biotechnology and Genetics School of Sciences, JAIN (Deemed to Be University), Bangalore, Karnataka, India.
- Centre for Research Impact & Outcome, Chitkara University Institute of Engineering and Technology, Chitkara University, Rajpura, Punjab, India.
ORCID-Profile: Faris Anad Muhammad
Zitieren
APA
Saadh, M. J., Muhammad, F. A., Albadr, R. J., Sanghvi, G., Jyothi, S. R., Kundlas, M., Joshi, K. K., Rakhmatullaev, A., Taher, W. M., Alwan, M., Jawad, M. J., & Ali Al-Nuaimi, A. M. (2025). Inflammasomes and Cardiovascular Disease: Linking Inflammation to Cardiovascular Pathophysiology. Scandinavian Journal of Immunology, 101(4). https://doi.org/10.1111/sji.70020
Vancouver
Saadh MJ, Muhammad FA, Albadr RJ, Sanghvi G, Jyothi SR, Kundlas M, et al. Inflammasomes and Cardiovascular Disease: Linking Inflammation to Cardiovascular Pathophysiology. Scandinavian Journal of Immunology. 2025;101(4). doi:10.1111/sji.70020
BibTeX
@article{Saadh2025,
author = {Saadh, Mohamed J and Muhammad, Faris Anad and Albadr, Rafid Jihad and Sanghvi, Gaurav and Jyothi, S Renuka and Kundlas, Mayank and Joshi, Kamal Kant and Rakhmatullaev, Akmal and Taher, Waam Mohammed and Alwan, Mariem and Jawad, Mahmood Jasem and Ali Al-Nuaimi, Ali M},
title = {Inflammasomes and Cardiovascular Disease: Linking Inflammation to Cardiovascular Pathophysiology},
journal = {Scandinavian Journal of Immunology},
year = {2025},
volume = {101},
number = {4},
doi = {10.1111/sji.70020}
}
EUVIMED